Literature DB >> 3266947

Does cyclosporin A adversely affect Pneumocystis carinii infection?

R J McGonigle1, M Beaman, J Stone, J Young, J Michael, D Adu.   

Abstract

Fourteen immunosuppressed patients with Pneumocystis carinii infection presented in two clusters that were separated by 2 years. The diagnosis in all cases was made early by alveolar lavage with cytology. The first group of seven patients was immunosuppressed with cyclophosphamide or azathioprine and prednisolone. All recovered with high dose co-trimoxazole. The second group of seven patients was on prednisolone and cyclosporin A. Despite identical treatment three patients died and a further two who survived lost their grafts from rejection. Our data suggest that cyclosporin A adversely affects the prognosis from Pneumocystis carinii infection and raises the question of prophylactic co-trimoxazole in these patients. The clustering of Pneumocystis carinii infection suggests the possibility of nosocomial transmission although in this study we were unable to implicate person-to-person spread of infection.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3266947      PMCID: PMC2428963          DOI: 10.1136/pgmj.64.755.659

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  15 in total

1.  Pneumocystis carinii infection.

Authors:  B A Burke; R A Good
Journal:  Medicine (Baltimore)       Date:  1973-01       Impact factor: 1.889

2.  In vitro effects of antiprotozoan drugs and immune serum on Pneumocystis carinii.

Authors:  E L Pesanti
Journal:  J Infect Dis       Date:  1980-06       Impact factor: 5.226

3.  Symbiosis of Pneumocystis carinii and cytomegalovirus in a case of fatal pneumonia.

Authors:  P Ernst; M F Chen; N S Wang; M Cosio
Journal:  Can Med Assoc J       Date:  1983-05-01       Impact factor: 8.262

4.  Provocation of infection due to Pneumocystis carinii by cyclosporin A.

Authors:  W T Hughes; B Smith
Journal:  J Infect Dis       Date:  1982-05       Impact factor: 5.226

5.  Serial propagation of Pneumocystis carinii in cell line cultures.

Authors:  C R Latorre; A J Sulzer; L G Norman
Journal:  Appl Environ Microbiol       Date:  1977-05       Impact factor: 4.792

6.  Limited effect of trimethoprim-sulfamethoxazole prophylaxis on Pneumocystis carinii.

Authors:  W T Hughes
Journal:  Antimicrob Agents Chemother       Date:  1979-09       Impact factor: 5.191

7.  Natural mode of acquisition for de novo infection with Pneumocystis carinii.

Authors:  W T Hughes
Journal:  J Infect Dis       Date:  1982-06       Impact factor: 5.226

8.  Trimethoprim-sulfamethoxazole in the treatment of adults with pneumonia due to Pneumocystis carinii.

Authors:  L S Young
Journal:  Rev Infect Dis       Date:  1982 Mar-Apr

9.  Pneumocystis carinii infection: evidence for high prevalence in normal and immunosuppressed children.

Authors:  L L Pifer; W T Hughes; S Stagno; D Woods
Journal:  Pediatrics       Date:  1978-01       Impact factor: 7.124

10.  Trimethoprim-sulfamethoxazole for the treatment of Pneumocystis carinii pneumonia.

Authors:  D J Winston; W K Lau; R P Gale; L S Young
Journal:  Ann Intern Med       Date:  1980-06       Impact factor: 25.391

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.